BOAN BIOTECH News

BOAN BIOTECH: Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 November 2024

04:14 ET

BOAN BIOTECH: Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 October 2024

Nov 1 04:41 ET

BOAN BIOTECH: Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 September 2024

Oct 2 04:56 ET

BOAN BIOTECH: Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 August 2024

Sep 4 04:51 ET

BOAN BIOTECH: Articles of Association

Aug 28 05:04 ET

BOAN BIOTECH: PROPOSED AMENDMENTS TO THE ARTICLES OF ASSOCIATION

Aug 23 10:31 ET

BOAN BIOTECH: Next Day Disclosure Return

Aug 7 09:10 ET

BOAN BIOTECH: Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 July 2024

Aug 5 02:14 ET

BOAN BIOTECH: VOLUNTARY ANNOUNCEMENTAPPROVAL OBTAINED FOR INITIATING CLINICAL TRIALSFOR DULAGLUTIDE INJECTION (BA5101) IN THE U.S.

Aug 5 00:01 ET

BOAN BIOTECH: VOLUNTARY ANNOUNCEMENTAPPROVAL OBTAINED FOR INITIATING CLINICAL TRIAL FORTHE NOVEL ADC CANDIDATE BA1302 IN CHINA

Jul 25 04:41 ET

BOAN BIOTECH: VOLUNTARY ANNOUNCEMENTACCEPTANCE OF BLA IN CHINA FORAFLIBERCEPT INTRAVITREOUS INJECTION (BA9101)

Jul 16 07:00 ET

BOAN BIOTECH: Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 June 2024

Jul 2 05:58 ET

BOAN BIOTECH: Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 May 2024

Jun 3 23:08 ET

BOAN BIOTECH: VOLUNTARY ANNOUNCEMENTACCEPTANCE OF BLA IN CHINA FORDULAGLUTIDE INJECTION (BA5101)

May 27 08:54 ET

BOAN BIOTECH: VOLUNTARY ANNOUNCEMENTDENOSUMAB INJECTION (BOLUOJIA) FOR ONCOLOGYINDICATIONS APPROVED FOR MARKETING BY NMPA

May 27 00:06 ET

BOAN BIOTECH: Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 April 2024

May 5 23:17 ET

BOAN BIOTECH: FORM OF PROXY FOR USE AT ANNUAL GENERAL MEETING TO BE HELD ON 31 MAY 2024 (APPLICABLE TO HOLDERS OF H SHARES)

Apr 29 10:29 ET

BOAN BIOTECH: 2023 ENVIRONMENTAL, SOCIAL AND GOVERNANCE REPORT

Apr 29 10:27 ET

BOAN BIOTECH: VOLUNTARY ANNOUNCEMENTPHASE 3 CLINICAL TRIAL COMPLETED IN CHINA FOR AFLIBERCEPT INTRAVITREOUS INJECTION (BA9101) AND BLA TO BE FILED

Apr 8 04:31 ET

BOAN BIOTECH: Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 March 2024

Apr 7 23:49 ET